TFA
RYTM icon

Toth Financial Advisory’s Rhythm Pharmaceuticals RYTM Stock Holding History

Toth Financial Advisory’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$866K Sell
7,800
-2,200
-22% -$199K 0.08% 150
2026
Q1 		$870K Hold
10,000
– – 0.1% 139
2025
Q4 		$1.07M Hold
10,000
– – 0.12% 131
2025
Q3 		$1.01M Hold
10,000
– – 0.11% 135
2025
Q2 		$632K Buy
+10,000
New +$612K 0.07% 147

Other funds holding RYTM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
EWP
Elevation Wealth Partners Santa Rosa, California $334M AUM 26.48% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Toth Financial Advisory's RYTM Position: Q2 2026 in Review

Toth Financial Advisory reduced its Rhythm Pharmaceuticals (RYTM) stake by 22% in Q2 2026, selling an estimated $199K and leaving 7,800 shares worth $866K. The position accounts for 0.08% of the portfolio, ranked #150.

Toth Financial Advisory first reported a position in RYTM in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.07M in Q4 2025. 20 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Toth Financial Advisory held 7,800 shares of Rhythm Pharmaceuticals worth $866K as of Q2 2026.
  • Toth Financial Advisory sold 2,200 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $199K.
  • Rhythm Pharmaceuticals made up 0.08% of Toth Financial Advisory's portfolio in Q2 2026, its #150 holding.
  • Toth Financial Advisory first reported a position in Rhythm Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Toth Financial Advisory's Rhythm Pharmaceuticals position peaked at $1.07M in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.